Results 131 to 140 of about 6,510 (175)

RECQL4 requires PARP1 for recruitment to DNA damage, and PARG dePARylation facilitates its associated role in end joining. [PDF]

open access: yesExp Mol Med
Hussain M   +7 more
europepmc   +1 more source

Bifendate inhibits cell PARthanatos by activating the MEK/ERK pathway. [PDF]

open access: yesBiochem Biophys Rep
Hu AM, Chen M, Zhu CC, Zhu ZM, Xu XH.
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat

Brain Research, 2003
Poly(ADP-ribose) is synthesized from nicotinamide adenine dinucleotide (NAD(+)) by poly(ADP-ribose) polymerase (PARP) and degraded by poly(ADP-ribose) glycohydrolase (PARG). Overactivation of the poly(ADP-ribose) pathway increases nicotinamide and decreases cellular NAD(+)/ATP, which leads to cell death.
Xi-Chun M, Lu   +5 more
exaly   +3 more sources

DNA replication stress and emerging prospects for PARG inhibitors in ovarian cancer therapy

Progress in Biophysics and Molecular Biology, 2021
Poly (ADP-ribosyl)ation has central functions in maintaining genome stability, including facilitating DNA replication and repair. In cancer cells these processes are frequently disrupted, and thus interfering with poly (ADP-ribosyl)ation can exacerbate inherent genome instability and induce selective cytotoxicity. Indeed, inhibitors of poly (ADP-ribose)
Nisha Pillay   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy